Cantor Fitzgerald Maintains Overweight on SI-BONE, Maintains $25 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Ross Osborn maintains an Overweight rating on SI-BONE (NASDAQ:SIBN) and keeps the price target at $25.
February 27, 2024 | 2:12 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald reaffirms an Overweight rating on SI-BONE, with a steady price target of $25.
The reaffirmation of an Overweight rating and a steady price target by a reputable analyst like Ross Osborn suggests a positive outlook on SI-BONE's stock. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100